PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Jan-2024 Optimind Pharma - Debenture Conversion AccessWire
26-Jan-2024 InnoScot Health backs MHRA regulatory roadmap to aid medical device innovators InnoScot Health
26-Jan-2024 Galen announces exclusive licensing agreement with Almeda Pharmaceuticals AG for new Microtabs Plus product. Galen
26-Jan-2024 LEO Pharma announces positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE) LEO Pharma
26-Jan-2024 Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases Kyowa Kirin
26-Jan-2024 International life sciences marketing agency announces strategic rebrand ramarketing
26-Jan-2024 Fórsa and the European Biosafety Network call for greater protection for healthcare workers from exposure to hazardous medicinal products Fórsa
26-Jan-2024 Pistoia Alliance launches freely available IDMP Ontology 1.0, covering all five standards set by ISO The Pistoia Alliance
26-Jan-2024 Planet 13 to Restate Certain Previously Issued Financial Statements AccessWire
26-Jan-2024 Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) Epigenomics AG
26-Jan-2024 Nutriband CEO Publishes Letter to Shareholders AccessWire
26-Jan-2024 TRYP THERAPEUTICS AND EXOPHARM LIMITED SECURE PIVOTAL 2 CENT WAIVER FROM ASX Tryp Therapeutics Inc.
26-Jan-2024 Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX AccessWire
26-Jan-2024 Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza Lonza Group AG
26-Jan-2024 SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory SCHOTT Pharma AG & Co. KGaA
26-Jan-2024 Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook Sartorius Stedim Biotech SA
26-Jan-2024 Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin Lonza Group AG
26-Jan-2024 First 24/7 Weed Delivery Service in NYC Now Opens AccessWire
25-Jan-2024 Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split AccessWire
25-Jan-2024 Scientific Industries Announces Closing of $7.0 Million Private Placement AccessWire